Pancreatic Neoplasms
Nicholas J. Petrelli, MD, FACS, Consulting Editor This issue of the Surgical Oncology Clinics of North America is devoted to pancreatic neoplasms. The guest editor is Nipun Merchant, MD. Dr…
Thoracoscopic Lobectomy for Non–small Cell Lung Cancer
Lobectomy is the gold standard treatment in operable patients with surgically resectable non–small cell lung cancer. Thoracoscopic lobectomy has emerged as an option for surgeons facile with the technique. Video-assisted…
Local Therapy Indications in the Management of Patients with Oligometastatic Non–Small Cell Lung Cancer
Advances in surgical, radiation, and interventional radiology therapies carry a reduction in morbidity associated with therapy. Aggressive management of patients with oligometastatic non–small cell lung cancer offers the potential for…
Targeted Therapy and Immunotherapy for Lung Cancer
Targeted therapy and immunotherapy have changed the treatment paradigm of non–small cell lung cancer (NSCLC). Distinct molecular subtypes of NSCLC have been described over the past 20 years, enabling the emergence…
Adjuvant Therapy for Stage I and II Non–Small Cell Lung Cancer
Patients with stage I and stage II non–small cell lung cancer undergoing complete resection have a 40% to 70% 5-year overall survival despite optimal local therapy. Chemotherapy administered after complete…
Neoadjuvant Therapy in Non–Small Cell Lung Cancer
Locally advanced (stage IIIA) non–small cell lung cancer (NSCLC) is confined to the chest, but requires more than surgery to maximize cure. Therapy given preoperatively is termed neoadjuvant , whereas…
Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard…
Robotic Lung Resection for Non–Small Cell Lung Cancer
Robotic-assisted pulmonary lobectomy can be considered for patients able to tolerate conventional lobectomy. Contraindications to resection via thoracotomy apply to patients undergoing robotic lobectomy. Team training, familiarity with equipment, troubleshooting,…
Pneumonectomy for Non–Small Cell Lung Cancer
Lung cancer is the leading cause of cancer deaths and its incidence continues to increase. Emerging therapies as part of a multimodal approach are making more patients eligible for surgical…
Mediastinal Staging in Non–Small Cell Lung Cancer
In the absence of distant metastases, lung cancer treatment is determined by the results of mediastinal lymph node staging. Occult mediastinal lymph node metastases can be missed by radiologic and…
